Skip to main content

Report of a Large Brazilian Family With a Very Attenuated Form of Hunter Syndrome (MPS II)

  • Case Report
  • Chapter
  • First Online:
JIMD Reports - Case and Research Reports, 2012/1

Abstract

Hunter syndrome, or Mucopolysaccharidosis type II (MPS II), is a rare X-linked recessive disorder caused by a deficiency of the lysosomal enzyme iduronate-2-sulfatase (IDS). The phenotypic spectrum varies from severe to attenuated clinical forms. We report a large Brazilian family with 16 affected individuals exhibiting a very attenuated form of MPS II. Fourteen female carriers were also identified. Twelve affected male patients, whose ages ranged from 1 to 35 years, were examined. Molecular analysis showed a novel missense mutation (p.A77D) in the IDS gene, confirming the diagnosis. Nine of the family members presented some degree of heart damage, though only the proband became symptomatic and required heart transplantation. One 19-year-old adult and 1-year-old twin boys each had a normal echocardiogram. Short stature was found in two adults while macrocephaly was found in one; the remaining adults had anthropometric measures within normal range. All affected adults had normal cognitive development and were able to perform normal daily activities, except one who had mild learning disability. Two patients died due to natural causes beyond 70 years of age. The female carriers did not present any signs of disease. In this large family with a mild form of MPS II and variable degree of clinical manifestations, it is noteworthy that several affected individuals have remained asymptomatic even at advanced age and even without enzyme replacement therapy.

Communicated by: Ed Wraith

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • DiFerrante N, Nichols BL (1972) A case of the Hunter syndrome with progeny. Johns Hopkins Med J 130(5):325–328

    PubMed  CAS  Google Scholar 

  • Martin R, Beck M, Eng C, Giugliani R, Harmatz P, Muñoz V, Muenzer J (2008) Recognition and diagnosis of mucopolysaccharidosis II (Hunter syndrome). Pediatrics 121(2):e377–e386, Review

    Article  PubMed  Google Scholar 

  • Muenzer J, Beck M, Eng CM, Escolar ML, Giugliani R, Guffon NH, Harmatz P, Kamin W, Kampmann C, Koseoglu ST, Link B, Martin RA, Molter DW, Muñoz Rojas MV, Ogilvie JW, Parini R, Ramaswami U, Scarpa M, Schwartz IV, Wood RE, Wraith E (2009) Multidisciplinary management of Hunter syndrome. Pediatrics 124(6):e1228–e1239, Epub 2009 Nov 9. Review

    Article  PubMed  Google Scholar 

  • Muenzer J, Beck M, Eng CM, Giugliani R, Harmatz P, Martin R, Ramaswami U, Vellodi A, Wraith JE, Cleary M, Gucsavas-Calikoglu M, Puga AC, Shinawi M, Ulbrich B, Vijayaraghavan S, Wendt S, Conway AM, Rossi A, Whiteman DA, Kimura A (2011) Long-term, open-labeled extension study of idursulfase in the treatment of Hunter syndrome. Genet Med 13(2):95–101

    Article  PubMed  CAS  Google Scholar 

  • Sasaki CT, Ruiz R, Gaito R Jr, Kirchner JA, Seshi B (1987) Hunter’s syndrome: a study in airway obstruction. Laryngoscope 97(3 Pt 1):280–285

    PubMed  CAS  Google Scholar 

  • Scarpa M (2011) Mucopolysaccharidosis Type II. In: GeneReviews at GeneTests – Medical Genetics Information Resource (database online). Copyright, University of Washington, Seattle. 1997–2011. Available at http://www.genetests.org. Accessed 24 May 2011

  • Wraith JE, Beck M, Giugliani R, Clarke J, Martin R, Muenzer J (2008a) HOS Investigators Initial report from the Hunter Outcome Survey. Genet Med 10:508–516

    Article  PubMed  Google Scholar 

  • Wraith JE, Scarpa M, Beck M, Bodamer OA, De Meirleir L, Guffon N, Lund AM, Malm G, Van der Ploeg AT, Zeman J (2008b) Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy. Eur J Pediatr 167:267–277

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C. A. Kim .

Editor information

Editors and Affiliations

Additional information

Communicated by: Claude Bachmann

Appendices

Conflict of Interest

There are no conflicts to disclose.

Synopsis

Report of a large Brazilian family with a novel missense mutation on IDS gene, displaying a very attenuated form of MPS II, with 16 affected individuals, most of them asymptomatic.

Rights and permissions

Reprints and permissions

Copyright information

© 2011 SSIEM and Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Quaio, C.R.D.C. et al. (2011). Report of a Large Brazilian Family With a Very Attenuated Form of Hunter Syndrome (MPS II). In: JIMD Reports - Case and Research Reports, 2012/1. JIMD Reports, vol 4. Springer, Berlin, Heidelberg. https://doi.org/10.1007/8904_2011_90

Download citation

  • DOI: https://doi.org/10.1007/8904_2011_90

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-25751-3

  • Online ISBN: 978-3-642-25752-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics